Posted 10/17/2023, 11:37:30 AM
VitaDAO Invests $300K in Cancer Research Startup Matrix Biosciences, Plans Further Funding via IP Tokens
- VitaDAO community funds early-stage cancer research through new biotech company Matrix Biosciences
- Initial $300K investment from community treasury, more funding planned via IP tokenization
- Research utilizes high molecular weight hyaluronic acid (HMW-HA) found in naked mole rats
- 35 VITA token holders voted, with majority 30 supporting the proposal
- Matrix Bio can raise additional funds by issuing IP tokens after initial experiments
- VitaDAO has previously funded up to $1M of a project before outside investors get involved